Manuel
Arrojo Romero
Karolinska Institute
Estocolmo, SueciaPublicaciones en colaboración con investigadores/as de Karolinska Institute (5)
2024
-
Revealing the reporting disparity: VigiBase highlights underreporting of clozapine in other Western European countries compared to the UK
Schizophrenia Research, Vol. 268, pp. 175-188
2023
-
Meta-analysis of the effects of adjuvant drugs in co-occurring bipolar and substance use disorder
Revista de Psiquiatria y Salud Mental
2022
-
Mapping genomic loci implicates genes and synaptic biology in schizophrenia
Nature, Vol. 604, Núm. 7906, pp. 502-508
2014
-
Common variant at 16p11.2 conferring risk of psychosis
Molecular Psychiatry, Vol. 19, Núm. 1, pp. 108-114
2011
-
Common variants at VRK2 and TCF4 conferring risk of schizophrenia
Human Molecular Genetics, Vol. 20, Núm. 20, pp. 4076-4081